Literature DB >> 19845569

Sublingual immunotherapy: adherence based on timing and monitoring control visits.

D Vita1, L Caminiti, P Ruggeri, G B Pajno.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19845569     DOI： 10.1111/j.1398-9995.2009.02223.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  10 in total

Review 1.  Adherence to Sublingual Immunotherapy.

Authors:  Cristoforo Incorvaia; Marina Mauro; Gualtiero Leo; Erminia Ridolo
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 2.  Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma.

Authors:  Huabin Li; Shi Chen; Lei Cheng; Yinshi Guo; He Lai; Yong Li; Xiaoping Lin; Zheng Liu; Qianhui Qiu; Jie Shao; Li Shi; Man Tian; Chengshuo Wang; Hongtian Wang; Xueyan Wang; Qingyu Wei; Yongxiang Wei; Li Xiang; Qintai Yang; Changqing Zhao; Huanping Zhang; Yuxiang Zhi; Junxiao Gao; Quansheng Li; Juan Liu; Kuiji Wang; Wencheng Zhou; Luo Zhang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

3.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Authors:  Giorgio Walter Canonica; Linda Cox; Ruby Pawankar; Carlos E Baena-Cagnani; Michael Blaiss; Sergio Bonini; Jean Bousquet; Moises Calderón; Enrico Compalati; Stephen R Durham; Roy Gerth van Wijk; Désirée Larenas-Linnemann; Harold Nelson; Giovanni Passalacqua; Oliver Pfaar; Nelson Rosário; Dermot Ryan; Lanny Rosenwasser; Peter Schmid-Grendelmeier; Gianenrico Senna; Erkka Valovirta; Hugo Van Bever; Pakit Vichyanond; Ulrich Wahn; Osman Yusuf
Journal:  World Allergy Organ J       Date:  2014-03-28       Impact factor: 4.084

4.  Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany.

Authors:  Bram G Verheggen; Kirsten Y Westerhout; Carl H Schreder; Matthias Augustin
Journal:  Clin Transl Allergy       Date:  2015-01-21       Impact factor: 5.871

5.  Patients' compliance with different administration routes for allergen immunotherapy in Germany.

Authors:  Anne-Marie Egert-Schmidt; Jan-Marcel Kolbe; Sabine Mussler; Susanne Thum-Oltmer
Journal:  Patient Prefer Adherence       Date:  2014-10-24       Impact factor: 2.711

6.  Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain.

Authors:  Tomás Chivato; Pedro Álvarez-Calderón; Carmen Panizo; Ricardo Abengozar; César Alías; Ali Al-Baech; José Arias-Irigoyen; M José Caballero; Lluis Conill; Silvia de Miguel; Rafael Laguna; Joan Martínez-Benazet; Francisco Matoses; Jose Camilo Martínez-Alonso; Lourdes Mendizábal; Celsa Pérez-Carral; Carlos Puerto; Joan Serra-Batllés; Adolfo Vélez; Jonathan Vicente; Fernando de la Torre
Journal:  Clin Mol Allergy       Date:  2017-01-06

7.  Physician's recommendation and explanation is important in the initiation and maintenance of allergen immunotherapy.

Authors:  Young-Hee Nam; Soo-Keol Lee
Journal:  Patient Prefer Adherence       Date:  2017-03-01       Impact factor: 2.711

8.  Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.

Authors:  Christian Vogelberg; Bernd Brüggenjürgen; Hartmut Richter; Marek Jutel
Journal:  Patient Prefer Adherence       Date:  2020-05-13       Impact factor: 2.711

9.  Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic.

Authors:  Ilkay Koca Kalkan; Hale Ates; Kurtulus Aksu; Selma Yesilkaya; Musa Topel; Dilek Cuhadar Ercelebi; Suleyman Turkyilmaz; Ali Oncul; Senay Demir
Journal:  World Allergy Organ J       Date:  2021-06-08       Impact factor: 4.084

10.  Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.

Authors:  Melina Makatsori; Gianenrico Senna; Constantinos Pitsios; Ramon Lleonart; Ludger Klimek; Carlos Nunes; Maia Rukhadze; Barbara Rogala; Radoslaw Gawlik; Petr Panzner; Oliver Pfaar; Moises Calderon
Journal:  Clin Transl Allergy       Date:  2015-04-27       Impact factor: 5.871
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.